Neural Stem Cell Grafting for CNS Lesion Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for central nervous system (CNS) lesions, such as spinal cord injuries, have failed to achieve significant axonal regeneration and functional synaptic junction formation due to the inhibitory environment of the adult CNS, despite efforts to modify the growth inhibitory milieu.
Innovation Solution
The method involves grafting undifferentiated neural stem cells at an early stage of development, suspended in a transplantation matrix like fibrin glue, directly into the lesion site, with optional supplementation of growth factors like BDNF, allowing the cells to differentiate and extend axons without needing to modify the CNS environment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional therapies attempt to modify the inhibitory CNS environment to promote axonal regeneration, then the growth inhibitory milieu is targeted, but significant axonal regeneration and functional synaptic junction formation still fail to occur
Solution Approach 1:
The patent uses neural stem cells as intermediary agents that are transplanted into the lesion site. These cells serve as mediators that bridge the gap between the damaged CNS tissue and the goal of regeneration, providing intrinsic growth capacity without requiring extensive modification of the host CNS environment. The neural stem cells differentiate into neurons and extend axons across the lesion, facilitating regeneration through their inherent plasticity rather than by altering the external environment.
Solution Approach 2:
The patent changes the key parameter from modifying the external CNS environment to introducing cells with different intrinsic properties. By transplanting neural stem cells that possess inherent growth capacity and plasticity, the system exploits parameter changes at the cellular level rather than attempting to alter the molecular composition of the CNS milieu. This approach bypasses the need to overcome inhibitory factors by changing the regenerative capacity of the introduced cells themselves.
2Reliability
If the inhibitory CNS environment is left unmodified, then the natural growth inhibitory factors remain present, but neural stem cells can still extend axons and form functional synaptic junctions when grafted at early developmental stages
Solution Approach 1:
The patent converts the harmful effect of the inhibitory CNS environment into a beneficial outcome by selecting neural stem cells that are inherently resistant to or unaffected by these inhibitory factors. The early developmental stage cells possess intrinsic properties that allow them to thrive and regenerate despite the presence of chondroitin sulfate proteoglycan and other inhibitory molecules. The harm of the inhibitory environment is bypassed by using cells whose regenerative capacity is not dependent on environmental permissiveness.
Solution Approach 2:
The neural stem cells perform self-service by relying on their own intrinsic growth capacity and plasticity rather than requiring external environmental modification to succeed. The grafted cells autonomously differentiate, extend processes, and form functional connections without needing the host CNS environment to be altered. This self-sufficient approach allows regeneration to proceed despite the presence of inhibitory factors in the host tissue.
3Length of moving object
If undifferentiated neural stem cells are grafted into the lesion site, then extensive axonal regeneration occurs over long distances, but the transplantation process and cell handling requirements become complex
Solution Approach 1:
The patent applies preliminary action by selecting and preparing neural stem cells at an early developmental stage before transplantation. The cells are harvested and maintained in an undifferentiated state ex vivo, which is the optimal condition for maximizing their regenerative potential. This preliminary preparation ensures that when the cells are grafted into the lesion, they possess the inherent capacity to extend axons over long distances without requiring additional environmental manipulation or complex post-transplantation support.
Data Source
AI summary
Methods for inducing non-embryonic lesioned central nervous system neurons to survive, integrate, extend axons over long distances, induce intra-lesion ingrowth of neurons into the lesion from host tissue and form synapses in vivo. Pluripotent neural stem cells are grafted into the lesioned CNS tissue within a tissue adhesive suspension, optionally in the presence of growth factors. No modification of the neuronal regenerative inhibitory environment of the CNS is necessary.